PATENT CLAIM ANALYSIS

Application Number: 16091373
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["514", "269000"]

Abstract:
An object is to provide a pharmaceutical composition containing a compound having an excellent effect of preventing or treating lactic acidosis. Provided is a pharmaceutical composition for preventing or treating lactic acidosis, including, as an active ingredient, a compound represented by the general formula (I) or a pharmacologically acceptable salt thereof: in the general formula (I), R 1  represents a hydroxy C 1  to C 6  alkyl group, a C 2  to C 7  alkanoyl group, a C 2  to C 7  alkanoyl C 1  to C 6  alkyl group, a (C 1  to C 6  alkoxy)carbonyl group, a (C 1  to C 6  alkoxy)carbonyl C 1  to C 6  alkyl group, a carboxy group, or a carboxy C 1  to C 6  alkyl group.

Claim (Index 27):
The method according to  claim 17 , wherein the lactic acidosis comprises metformin-associated lactic acidosis.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 97.0
- Lexical Diversity: 2.64286
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13503340', '10925656', '12530507', '15287228', '10492831']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7448229484016783
- 35 USC 102 Novelty (BERT): 0.5098789684398626
- Combined Prediction Score: 0.7213285504054968
- Mean Citation Score: 227.355282
- Max Citation Score: 284.2221
- Similarity Product: 212.2853741646767

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test